Question: Are antiretrovirals effective against covid-19?

Answer passage (source: WHO):
page_title: Q&A: HIV, antiretrovirals and COVID-19
section_headers: What is WHO’s position on the use of antiretrovirals for the treatment of COVID-19?
section_content: Currently, there is insufficient data to assess the effectiveness of LPV/r or
other antivirals for treating COVID-19. Several countries are evaluating the
use of LPV/r and other antivirals and we welcome the results of these
investigations.
Again, as part of WHO’s response to the outbreak, the
WHO R&D Blueprint
has been activated to accelerate evaluation of diagnostics,
vaccines and therapeutics for this novel coronavirus. WHO has also designed a
set of procedures to assess the performance, quality and safety of medical
technologies during emergency situations.

Reviewer feedback on this answer:
It explains that they don't have enough info to give a real answer. It assures that more testing will be done in the future.
While this answers the question directly, it does not give much information on where the answer came from.

Reviewer ratings:
Excellent
Acceptable

Answer passage (source: WHO):
page_title: Q&A: HIV, antiretrovirals and COVID-19
section_headers: What studies on treatment and prevention of COVID-19 with antiretrovirals are being planned?
section_content: Several randomized trials are planned to assess the safety and efficacy of
using antiretroviral drugs – mainly LPV/r – for treating COVID-19, in
combination with other drugs. Results are expected from mid-2020 onwards.  

Reviewer feedback on this answer:
The response is relevant. It's open with how little data it has to give a legitimate answer.
This answer is direct and to the point, but could use more information.

Reviewer ratings:
Excellent
Acceptable

Answer passage (source: WHO):
page_title: Q&A: HIV, antiretrovirals and COVID-19
section_headers: Can antiretrovirals be used to treat COVID-19?
section_content: Several studies have suggested that patients infected with the virus causing
COVID-19, and the related coronavirus infections (SARS-CoV and MERS-CoV) had
good clinical outcomes, with almost all cases recovering fully. In some cases,
patients were given an antiretroviral drug: lopinavir boosted with ritonavir
(LPV/r). These studies were mostly carried out in HIV-negative individuals.
It is important to note that these studies using LPV/r had important
limitations. The studies were small, timing, duration and dosing for treatment
were varied and most patients received co-interventions/co-treatments which
may have contributed to the reported outcomes.
While the evidence of benefit of using antiretrovirals to treat coronavirus
infections is of very low certainty, serious side effects were rare. Among
people living with HIV, the routine use of LPV/r as treatment for HIV is
associated with several side effects of moderate severity. However, as the
duration of treatment in patients with coronavirus infections was generally
limited to a few weeks, these occurrences can be expected to be low or less
than that reported from routine use.

Reviewer feedback on this answer:
It talks a lot about the studies that were done to see what works on the virus. It admits that they're uncertain about the effectiveness of the drugs.
This answer relates to the question and gives plenty of information.

Reviewer ratings:
Acceptable
Excellent